Companies › ABT
ABBOTT LABS (ABT)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0000001800 · EDGAR filings · Updated 2026-07-28
ABBOTT LABS (ABT) has reported institutional ownership of 79.4%, with 3,061 institutional managers holding positions valued at $141.2B per the latest 13F reporting period. The company has 7 bond series in the registry.
Filings this week (1)
- 2026-07-28 — Quarterly report (10-Q) filed
Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.
Latest updates
- 2026-07-16 — Current report (8-K) filed
- 2026-07-01 — Insider transaction reported (Form 4)
- 2026-07-01 — Insider transaction reported (Form 4)
- 2026-07-01 — Insider transaction reported (Form 4)
- 2026-07-01 — Insider transaction reported (Form 4)
- 2026-07-01 — Insider transaction reported (Form 4)
- 2026-07-01 — Insider transaction reported (Form 4)
- 2026-06-29 — Insider transaction reported (Form 4)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, ABBOTT LABS has 3,061 institutional holders and institutional ownership of 79.4%.
| # | Institution | Reported value | % of tracked total |
|---|---|---|---|
| 1 | BlackRock, Inc. | $15.0B | 10.6% |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | $11.6B | 8.2% |
| 3 | STATE STREET CORP | $8.17B | 5.8% |
| 4 | Capital Research Global Investors | $5.11B | 3.6% |
| 5 | VANGUARD PORTFOLIO MANAGEMENT LLC | $4.92B | 3.5% |
| 6 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $4.67B | 3.3% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | $4.00B | 2.8% |
| 8 | Capital International Investors | $3.85B | 2.7% |
| 9 | MORGAN STANLEY | $3.09B | 2.2% |
| 10 | WELLINGTON MANAGEMENT GROUP LLP | $2.78B | 2.0% |
Full holder history and quarter-over-quarter changes are available inside the app.
Insider activity
Insiders reported 49 transactions (3 buys, 9 sells) across 22 reporting insiders, with a net reported value of $1.33M.
Quarterly net insider value, as reported in Form 4 filings.
Debt profile
7 active bond series in the registry, coupons ranging 3.70%–5.60%, maturities through 2066, built from the company's own prospectus filings.
Debt maturity schedule
Principal coming due by year for ABBOTT LABS, from the company's own SEC prospectus filings (424B) tracked by Sightfile.
| Year | Bond series maturing | Known principal due |
|---|---|---|
| 2026 | 1 | — |
| 2028 | 1 | — |
| 2029 | 2 | — |
| 2030 | 1 | — |
| 2031 | 1 | — |
| 2033 | 1 | — |
| 2036 | 2 | — |
| 2037 | 1 | — |
| 2038 | 1 | — |
| 2039 | 1 | — |
| 2040 | 1 | — |
| 2043 | 1 | — |
Coupons, seniority and prospectus links for each series are available inside the app.
Fails-to-deliver
The SEC's fails-to-deliver file for 2026-06-29 reports 12,621 failed-to-deliver shares ($1.19M) for ABT — an official data point published by the SEC, shown as reported.
Related companies
AMGEN INC (AMGN) · ASTRAZENECA PLC (AZN) · GILEAD SCIENCES INC (GILD) · INTUITIVE SURGICAL INC (ISRG) · PFIZER INC (PFE) · STRYKER CORP (SYK)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-28.